» Articles » PMID: 39026460

Global Burden and Attributable Risk Factors of Breast Cancer in Young Women: Historical Trends from 1990 to 2019 and Forecasts to 2030 by Sociodemographic Index Regions and Countries

Overview
Journal J Glob Health
Date 2024 Jul 19
PMID 39026460
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Breast cancer in young women (BCY) is much less common but has significant health sequelae and societal costs. We aimed to evaluate the global and regional burden of breast cancer in women aged 15-39 years from 1990 to 2019.

Methods: We collected detailed data on breast cancer from the Global Burden of Disease Study 2019 (GBD 2019) Data Resources. The age-standardised incidence rate (ASIR), age-standardised mortality rate (ASMR), age-standardised disability-adjusted life years rate (ASDR), and estimated annual percentage change (EAPC) were used to assess the disease burden of BCY. The Bayesian Age-Period-Cohort model was used to forecast disease burden from 2020 to 2030.

Results: From 1990 to 2019, significant increases in ASIR were found for BCY (EAPC = 0.59, 95% confidence interval (CI) = 0.5 to 0.68), whereas decreases in ASMR (EAPC = -0.41, 95% CI = -0.53 to -0.3) and ASDR (EAPC = -0.35, 95% CI = -0.46 to -0.24). Across countries with varying sociodemographic indexes (SDI), all regions showed an upward trend in BCY morbidity, except for countries with a high SDI. While mortality and DALYs rates have decreased in countries with high, high-middle, and middle SDI, they have increased in countries with low-middle and low SDI. Countries with lower SDIs are projected to bear the greatest burden of BCY over the next decade, including both low and low-middle categories. Alcohol use was the main risk factor attributed to BCY deaths in most countries, while exposure to second hand smoke was the predominant risk factor for BCY deaths in middle and low-middle SDI countries.

Conclusions: The burden of breast cancer in young women is on the rise worldwide, and there are significant regional differences. Countries with a low-middle or low SDI face even more challenges, as they experienced a more significant and increasing BCY burden than countries with higher SDIs.

Citing Articles

Development of a prognostic model based on the ceRNA network in Triple-Negative Breast cancer.

Zhu Y, Wang J, Xu B PeerJ. 2025; 13:e19063.

PMID: 40034665 PMC: 11874946. DOI: 10.7717/peerj.19063.


Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter, observational, real-world study.

Sang D, Su Y, Zhang Y, Guan Y, Fan S, Zhang J Ther Adv Med Oncol. 2025; 17:17588359251318853.

PMID: 40034603 PMC: 11873904. DOI: 10.1177/17588359251318853.

References
1.
Fanakidou I, Zyga S, Alikari V, Tsironi M, Stathoulis J, Theofilou P . Mental health, loneliness, and illness perception outcomes in quality of life among young breast cancer patients after mastectomy: the role of breast reconstruction. Qual Life Res. 2017; 27(2):539-543. DOI: 10.1007/s11136-017-1735-x. View

2.
Fu J, Wu L, Fu W, Tan Y, Xu T, Hong Z . How Young Is Too Young in Breast Cancer?-Young Breast Cancer Is Not a Unique Biological Subtype. Clin Breast Cancer. 2017; 18(1):e25-e39. DOI: 10.1016/j.clbc.2017.05.015. View

3.
Zhang J, Ma B, Han X, Ding S, Li Y . Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10-24 years from 1990 to 2019: a trend analysis based on the Global Burden of Disease Study 2019. Lancet Child Adolesc Health. 2022; 6(11):763-776. DOI: 10.1016/S2352-4642(22)00219-X. View

4.
Lv L, Zhao B, Kang J, Li S, Wu H . Trend of disease burden and risk factors of breast cancer in developing countries and territories, from 1990 to 2019: Results from the Global Burden of Disease Study 2019. Front Public Health. 2023; 10:1078191. PMC: 9884979. DOI: 10.3389/fpubh.2022.1078191. View

5.
Richardson T, Sanderson E, Elsworth B, Tilling K, Davey Smith G . Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study. BMJ. 2020; 369:m1203. PMC: 7201936. DOI: 10.1136/bmj.m1203. View